Biodesix to Participate in Three Investor Conferences in November
LOUISVILLE, Colo., Oct. 29, 2024 ( GLOBE NEWSWIRE ) -- Biodesix, Inc. ( Nasdaq: BDSX ) , a leading diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer, and Robin Cowie, Chief Financial Officer, will participate in three upcoming ...
| Ticker |
Sentiment |
Impact |
|
BDSX
|
Somewhat Bullish
|
63 %
|
|
CCORF
|
Neutral
|
14 %
|
|
BIO
|
Neutral
|
14 %
|
